STUDIO PARIS LIMITED

Company number 13158931 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

STUDIO PARIS LIMITED - Analysis Report

Company Number: 13158931

Analysis Date: 2025-07-20 17:49 UTC

Financial Health Assessment Report for STUDIO PARIS LIMITED
As of 31 March 2024


1. Financial Health Score: Grade D

Explanation:
The company shows some signs of recovery compared to prior years, with net current assets turning positive in the latest financial year, indicating a modest improvement in short-term liquidity. However, persistent negative net assets and shareholders’ funds reflect ongoing accumulated losses and a weakened equity base. This places the company in a vulnerable financial position, though not yet in critical distress.


2. Key Vital Signs

Metric 2024 Value Interpretation
Net Assets (Equity) -£69,851 Negative equity signals accumulated losses and insolvency risk.
Net Current Assets (Working Capital) £10,576 Positive working capital shows improved short-term liquidity. Healthy cash flow likely enabling operations.
Cash at Bank £101,047 Strong cash position relative to recent years; a good liquidity cushion.
Current Liabilities £117,573 High current liabilities, but manageable given cash and current assets.
Long-term Liabilities £146,743 Significant long-term debt, which pressures financial stability.
Share Capital £1.00 Minimal equity capital base, indicating reliance on retained earnings or debt.
Fixed Assets (Net) £66,316 Decreasing fixed assets may indicate asset disposals or depreciation impact.
Average Employees 11 Slight increase in workforce, indicating business activity growth.

3. Diagnosis: Financial Symptoms and Underlying Health

  • Symptoms of Distress:
    The company has been carrying a persistent negative net asset position since incorporation, currently at about -£70k, which is a "chronic illness" in financial health terms. This suggests accumulated losses or insufficient capital injections.

  • Signs of Improvement:
    Notably, net current assets improved from a large negative value (~-£146k in 2023) to a positive £10.5k in 2024, reflecting better short-term liquidity — akin to stabilising a patient’s vital signs after a critical episode. Cash reserves have increased, indicating stronger cash flow management or capital inflows.

  • Debt Burden:
    Long-term creditors increased substantially to £146,743, which is a significant liability requiring careful management. This is comparable to a patient with underlying chronic conditions needing long-term treatment.

  • Working Capital Management:
    Positive working capital suggests the company can meet immediate obligations without stress, an encouraging sign of operational "circulation."

  • Equity Deficiency:
    The shareholder funds remain negative, meaning the company is technically insolvent on a balance sheet basis. This condition requires urgent attention to avoid worsening financial health.

  • Business Context:
    Operating in the take-away food sector (SIC 56103), a competitive and often low-margin industry, the company’s financial struggles could be linked to startup costs, market competition, or operational inefficiencies.


4. Recommendations: Prescription for Financial Wellness

  • Capital Injection or Restructuring:
    Consider equity injection or debt restructuring to repair the negative equity "immune deficiency." Fresh capital would strengthen the balance sheet and improve creditor confidence.

  • Cash Flow Monitoring:
    Maintain or improve cash reserves to ensure liquidity remains healthy. Implement strict receivables and payables management to sustain positive net current assets.

  • Cost Control and Profitability:
    Review cost structure, especially fixed and operational expenses, to improve profitability and reduce accumulated losses. Enhancing margins could be life-saving for long-term survival.

  • Debt Management:
    Engage with creditors to possibly refinance or extend payment terms on long-term liabilities to alleviate pressure on cash flow.

  • Strategic Review:
    Analyze market positioning and operational efficiency in the take-away food sector. Innovation, pricing strategy, and marketing may help improve top-line revenue and overall business vitality.

  • Regular Financial Health Checks:
    Adopt ongoing monitoring of key financial ratios and metrics to detect early symptoms of distress and act proactively.


Executive Summary

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.